Top Markets
#1 Islamic Coin Islamic Coin +152.22%
#2 Bitway Bitway +47.12%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.32%
#4 Starpower Starpower +30.97%
#5 Pleasing Gold Pleasing Gold +28.73%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.50%
#7 Pons Pons +21.12%
#8 aelf aelf +18.98%
#9 Venom Venom +15.90%
#10 Decred Decred +14.18%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Rank in Stocks #29826
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Share Price
$7.00
Last synced: 2026-08-17
Market Cap
$19.47M
Change (1 day)
0.00%
Change (1 year)
-35.19%
Country
CA
Trade Devonian Health Group Inc. (DVHGF)

Category

Healthcare
Revenue for Devonian Health Group Inc. (DVHGF)
Revenue in Aug 2026 TTM: 0
According to Devonian Health Group Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Devonian Health Group Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR